Penserra Capital Management LLC Poseida Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$1.62 - $2.79 $21,920 - $37,751	-13,531 Reduced 27.6%	35,496 $84,000
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.4 $47,836 - $97,977	28,817 Added 142.59%	49,027 $86,000
Q1 2023 Apr 24, 2023	SELL	$3.08 - $8.73 $25,810 - $73,157	-8,380 Reduced 29.31%	20,210 $62,000
Q4 2022 Feb 13, 2023	SELL	$3.33 - $6.38 $143,180 - $274,320	-42,997 Reduced 60.06%	28,590 $151,000
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $173,956 - $322,857	71,587 New	71,587 $252,000
Q4 2021 Feb 15, 2022	SELL	$6.23 - $7.6 $8,877 - $10,830	-1,425 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.09 - $10.71 $70 - $107	10 Added 0.71%	1,425 $10,000
Q2 2021 Aug 12, 2021	BUY	$7.96 - $10.07 $119 - $151	15 Added 1.07%	1,415 $14,000
Q1 2021 May 13, 2021	SELL	$8.51 - $11.91 $170 - $238	-20 Reduced 1.41%	1,400 $13,000
Q4 2020 Feb 12, 2021	BUY	$8.29 - $11.7 $11,771 - $16,614	1,420 New	1,420 $15,000

103

38.7M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.